Coffee intake, smoking, and pulmonary function in the atherosclerosis risk in communities study

American Journal of Epidemiology

Volumn 169, Issue 12, 2009, Pages 1445-1453

  Nettleton, Jennifer A ^a,b   Follis, Jack L ^a   Schabath, Matthew B ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Coffee; Forced expiratory volume; Lung diseases; Respiratory function tests; Smoking; Vital capacity

Indexed keywords

ANTIOXIDANT; CAFFEINE; FLAVONOID; PHENOL DERIVATIVE; POLYPHENOLS;

ANTIOXIDANT; CARDIOVASCULAR DISEASE; COFFEE; COHORT ANALYSIS; DIET; FOOD INTAKE; RESPIRATORY DISEASE; RISK FACTOR; SMOKING;

ADULT; ARTICLE; ATHEROSCLEROSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COFFEE; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LIFESTYLE; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; RESPIRATORY TRACT DISEASE; RISK FACTOR; SMOKING; SPIROMETRY; COHORT ANALYSIS; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; HEALTH STATUS; LUNG; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITION; PATHOPHYSIOLOGY; PHYSIOLOGY; QUESTIONNAIRE; RISK; UNITED STATES; VITAL CAPACITY;

COFFEE; COHORT STUDIES; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; FLAVONOIDS; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMANS; LUNG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITION SURVEYS; ODDS RATIO; PHENOLS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RISK FACTORS; SMOKING; UNITED STATES; VITAL CAPACITY;

EID: 67649148486     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp068     Document Type: Article

References (41)

1. National Heart, Lung, and Blood Institute. Morbidity & Mortality: 2007 Chart Book on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD: National Heart, Lung, and Blood Institute; 2007.
2. Løkke A, Lange P, Scharling H, et al. Developing COPD: a 25 year follow up study of the general population. Thorax. 2006; 61(11):935-939.
3. Jiang R, Camargo CA Jr, Varraso R, et al. Consumption of cured meats and prospective risk of chronic obstructive pulmonary disease in women. Am J Clin Nutr. 2008;87(4):1002-1008.
4. Jiang R, Paik DC, Hankinson JL, et al. Cured meat consumption, lung function, and chronic obstructive pulmonary disease among United States adults. Am J Respir Crit Care Med. 2007;175(8):798-804.
5. Varraso R, Jiang R, Barr RG, et al. Prospective study of cured meats consumption and risk of chronic obstructive pulmonary disease in men. Am J Epidemiol. 2007;166(12):1438-1445.
6. Shahar E, Folsom AR, Melnick SL, et al. Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. Atherosclerosis Risk in Communities Study Investigators. N Engl J Med. 1994;331(4):228-233.
7. Kan H, Stevens J, Heiss G, et al. Dietary fiber, lung function, and chronic obstructive pulmonary disease in the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2008;167(5): 570-578.
8. Tabak C, Smit HA, Heederik D, et al. Diet and chronic obstructive pulmonary disease: independent beneficial effects of fruits, whole grains, and alcohol (the MORGEN study). Clin Exp Allergy. 2001;31(5):747-755.
9. Tabak C, Smit HA, Räsänen L, et al. Dietary factors and pulmonary function: a cross sectional study in middle aged men from three European countries. Thorax. 1999;54(11): 1021-1026.
10. Tabak C, Feskens EJ, Heederik D, et al. Fruit and fish consumption: a possible explanation for population differences in COPD mortality (the Seven Countries Study). Eur J Clin Nutr. 1998;52(11):819-825.
11. Takezaki T, Hirose K, Inoue M, et al. Dietary factors and lung cancer risk in Japanese: with special reference to fish consumption and adenocarcinomas. Br J Cancer. 2001;84(9): 1199-1206.
12. Natella F, Nardini M, Giannetti I, et al. Coffee drinking influences plasma antioxidant capacity in humans. J Agric Food Chem. 2002;50(21):6211-6216.
13. Aubier M. Effect of theophylline on diaphragmatic and other skeletal muscle function. J Allergy Clin Immunol. 1986;78(4): 787-792.
14. Aubier M, Murciano D, Viires N, et al. Diaphragmatic contractility enhanced by aminophylline: role of extracellular calcium. J Appl Physiol. 1983;54(2):460-464.
15. Sturani C, Papiris S, Grossi G, et al. Potential benefits from caffeine consumption in patients with pulmonary emphysema. Eur J Respir Dis Suppl. 1986;146:557-563.
16. Klatsky AL, Koplik S, Kipp H, et al. The confounded relation of coffee drinking to coronary artery disease. Am J Cardiol. 2008;101(6):825-827.
17. Kadlubar FF, Butler MA, Kaderlik KR, et al. Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. Environ Health Perspect. 1992;98:69-74.
18. Sesardic D, Boobis AR, Edwards RJ, et al. A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. Br J Clin Pharmacol. 1988;26(4):363-372.
19. Vistisen K, Loft S, Poulsen HE. Cytochrome P450 IA2 activity in man measured by caffeine metabolism: effect of smoking, broccoli and exercise. Adv Exp Med Biol. 1991;283:407-411.
20. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129(4):687-702.
21. Stevens J, Metcalf PA, Dennis BH, et al. Reliability of a food frequency questionnaire by ethnicity, gender, age and education. Nutr Res. 1996;16(5):735-745.
22. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122(1):51-65.
23. Paynter NP, Yeh HC, Voutilainen S, et al. Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus: The Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2006;164(11):1075-1084.
24. Schroeder EB, Welch VL, Couper D, et al. Lung function and incident coronary heart disease: The Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2003;158(12): 1171-1181.
25. Mannino DM, Reichert MM, Davis KJ. Lung function decline and outcomes in an adult population. Am J Respir Crit Care Med. 2006;173(9):985-990.
26. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis. 1981;123(6):659-664.
27. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36(5):936-942.
28. Joeres R, Klinker H, Heusler H, et al. Influence of smoking on caffeine elimination in healthy volunteers and in patients with alcoholic liver cirrhosis. Hepatology. 1988;8(3):575-579.
29. Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clin Pharmacokinet. 1999;36(6): 425-438.
30. Whitsett TL, Manion CV, Christensen HD. Cardiovascular effects of coffee and caffeine. Am J Cardiol. 1984;53(7):918-922.
31. Northrop-Clewes CA, Thurnham DI. Monitoring micronutrients in cigarette smokers. Clin Chim Acta. 2007;377(1-2):14-38.
32. Jiang R, Burke GL, Enright PL, et al. Inflammatory markers and longitudinal lung function decline in the elderly. Am J Epidemiol. 2008;168(6):602-610.
33. MacNee W. Oxidants/antioxidants and COPD. Chest. 2000; 117(5 suppl 1):303S-317S.
34. Romieu I, Trenga C. Diet and obstructive lung diseases. Epidemiol Rev. 2001;23(2):268-287.
35. Schünemann HJ, Grant BJ, Freudenheim JL, et al. The relation of serum levels of antioxidant vitamins C and E, retinol and carotenoids with pulmonary function in the general population. Am J Respir Crit Care Med. 2001;163(5):1246-1255.
36. Smit HA, Grievink L, Tabak C. Dietary influences on chronic obstructive lung disease and asthma: a review of the epidemiological evidence. Proc Nutr Soc. 1999;58(2): 309-319.
37. Gómez-Ruiz JA, Leake DS, Ames JM. In vitro antioxidant activity of coffee compounds and their metabolites. J Agric Food Chem. 2007;55(17):6962-6969.
38. Bonita JS, Mandarano M, Shuta D, et al. Coffee and cardiovascular disease: in vitro, cellular, animal, and human studies. Pharmacol Res. 2007;55(3):187-198.
39. Schroeder EB, Welch VL, Evans GW, et al. Impaired lung function and subclinical atherosclerosis. The ARIC Study. Atherosclerosis. 2005;180(2):367-373.
40. van Dam RM, Hu FB. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA. 2005;294(1): 97-104.
41. Willett WC. Nutritional Epidemiology. 2nd ed. New York, NY: Oxford University Press; 1998.